financetom
Business
financetom
/
Business
/
GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung'
May 26, 2025 12:48 PM

May 22 (Reuters) - The U.S. Food and Drug Administration

has approved British drugmaker GSK's asthma drug to

treat some patients with a chronic lung disease commonly known

as "smoker's lung", the company said on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ARS Pharmaceuticals Gets Up to $250 Million Loan to Back Neffy Commercialization
ARS Pharmaceuticals Gets Up to $250 Million Loan to Back Neffy Commercialization
Sep 29, 2025
04:46 PM EDT, 09/29/2025 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said Monday it has obtained a senior secured term loan facility of up to $250 million with an affiliate of RA Capital Management, its largest shareholder, and an affiliate of OMERS Life Sciences as lenders. ARS has borrowed an initial $100 million that will be mainly used to...
Metsera's MET-097i Delivers Weight Loss Gains, Moves to Phase 3 Trials
Metsera's MET-097i Delivers Weight Loss Gains, Moves to Phase 3 Trials
Sep 29, 2025
04:47 PM EDT, 09/29/2025 (MT Newswires) -- Metsera ( MTSR ) reported positive Phase 2b results for its ultra-long acting GLP-1 candidate MET-097i, demonstrating strong weight loss efficacy and good tolerability, with the data supporting a Phase 3 start later this year. In one study, MET-097i led to up to 14.1% placebo-adjusted weight loss at 28 weeks, showing no plateau...
UniQure Closes $345 Million Public Offering
UniQure Closes $345 Million Public Offering
Sep 29, 2025
04:48 PM EDT, 09/29/2025 (MT Newswires) -- UniQure ( QURE ) said Monday it closed an underwritten public offering of about 6.7 million shares at $47.50 per share, for gross proceeds of roughly $345 million. The offering includes 947,368 shares issued under the exercise in full by the underwriters of an option to buy more shares, and in lieu of...
BKV Closes $370 Million Acquisition of Bedrock's Barnett Shale Assets
BKV Closes $370 Million Acquisition of Bedrock's Barnett Shale Assets
Sep 29, 2025
04:42 PM EDT, 09/29/2025 (MT Newswires) -- BKV (BKV) said late Monday it closed the acquisition of equity interests in Bedrock Production, including Bedrock Energy Partners' Barnett Shale assets, for about $370 million. The deal adds 97,000 net acres, 108 million cubic feet equivalent per day of production, and midstream infrastructure in the Barnett Shale, the company said. BKV said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved